Sorafenib Related Compound 7
Product Type
Impurity Standards
CAT. No.
MRL-S07021
CAS. No.
2206827-12-3
Mol. F.
C16H17N3O4
Mol. Wt.
315.33
Synonyms
NA
Chemical Name
Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
Stock Status
Custom Synthesis
Sorafenib Related Compound 7 with CAS No:2206827-12-3 is an impurity standard of Sorafenib. Sorafenib is a medication used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant thyroid cancer. Chemically, it is a kinase inhibitor that targets multiple signaling pathways involved in tumor growth and angiogenesis. Sorafenib inhibits the activity of kinases such as Raf, VEGFR (vascular endothelial growth factor receptor), and PDGFR (platelet-derived growth factor receptor). By disrupting these pathways, sorafenib helps slow down cancer cell proliferation and reduce the growth of blood vessels that supply tumors. It is typically administered orally in tablet form and is considered an important therapeutic option in the management of certain advanced cancers. Buy high quality Sorafenib Related Compound 7 from from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Sorafenib Related Compound 7
Request for Quotation : Sorafenib Related Compound 7
Related Products
Sorafenib EP Impurity A
Sorafenib EP Impurity B
Sorafenib EP Impurity C
Sorafenib EP Impurity D
Sorafenib EP Impurity E
Sorafenib EP Impurity F
Sorafenib EP Impurity G
Sorafenib EP Impurity H
Sorafenib Impurity 1
Sorafenib Impurity 4
Sorafenib Impurity 5
Sorafenib N-Oxide
N-Desmethyl Sorafenib (Pyridine)-N-oxide
Sorafenib Hydroxydemethylamine
Sorafenib Impurity 3
Sorafenib Impurity 7
Sorafenib Impurity-II
4-Chloro-N-methylpyridine-2-carboxamide
N-Desmethyl Sorafenib
Sorafenib Tosylate
Sorafenib Carboxylic Acid Methyl Ester
Sorafenib Impurity 11
N-Methyl-4-phenoxypicolinamide
N-Methyl Picolinamide
